Lakefront Biotherapeutics NV (LKFT)

LKFT Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	66.81	87.87	64.24	166.8	508.12	2,233
Short-Term Investments	2,915	2,910	3,053	3,518	3,586	2,470
Cash & Short-Term Investments	2,982	2,998	3,118	3,685	4,094	4,703
Cash Growth	-9.55%	-3.83%	-15.39%	-10.00%	-12.95%	-8.88%
Accounts Receivable	21.74	9.57	32.47	17.49	28.19	91.79
Other Receivables	32.3	43.64	55.62	48.16	49.15	36.82
Receivables	54.03	53.2	88.09	65.66	77.34	128.6
Inventory	17.69	22.49	51.19	73.98	52.93	20.57
Prepaid Expenses	-	0.1	0.1	0.74	0.49	0.2
Other Current Assets	6.77	5.61	82.49	36.72	12.03	9.31
Total Current Assets	3,061	3,079	3,339	3,862	4,237	4,862
Property, Plant & Equipment	76.95	80.66	122.9	126.32	154.25	137.51
Long-Term Investments	47.93	46.81	253.12	13.58	-	-
Goodwill	-	-	70.01	69.56	69.81	-
Other Intangible Assets	0.75	0.85	157.68	119.19	136.1	48.31
Long-Term Deferred Tax Assets	0.16	0.2	1.47	1.13	1.36	4.03
Long-Term Deferred Charges	-	-	7.18	8.72	10.26	11.8
Other Long-Term Assets	164.33	177.37	183.9	157.32	125.72	129.66
Total Assets	3,372	3,407	4,136	4,357	4,734	5,193
Accounts Payable	95.77	32.62	64.23	134.65	133.3	134.3
Accrued Expenses	-	0.02	1.09	0.55	0.65	3.11
Current Portion of Leases	1.58	1.73	3.48	4.65	7.21	7.2
Current Income Taxes Payable	0.91	0.96	0.25	0.06	1.02	1.78
Current Unearned Revenue	0.03	0.03	232.48	256.27	365.63	419.87
Other Current Liabilities	2.13	117.51	33.56	32.04	14.73	0.2
Total Current Liabilities	100.42	152.86	335.08	428.22	522.54	566.47
Long-Term Leases	4.85	5.19	8.24	4.94	14.69	19.66
Long-Term Unearned Revenue	-	-	838.88	1,071	1,624	1,945
Pension & Post-Retirement Benefits	-	-	2.1	2.29	5.54	11.7
Long-Term Deferred Tax Liabilities	-	-	20.66	23.61	20.15	-
Other Long-Term Liabilities	13.79	12.6	33.82	31.57	21.81	7.13
Total Liabilities	119.06	170.65	1,239	1,562	2,208	2,550
Common Stock	293.94	293.94	356.44	356.44	356.11	354.58
Additional Paid-In Capital	2,737	2,737	2,737	2,737	2,736	2,730
Retained Earnings	228.33	210.58	-134.31	-228.27	-496.69	-367.21
Comprehensive Income & Other	-5.89	-5.64	-62.19	-69.6	-68.95	-74.41
Shareholders' Equity	3,253	3,236	2,897	2,796	2,526	2,643
Total Liabilities & Equity	3,372	3,407	4,136	4,357	4,734	5,193
Total Debt	6.44	6.92	11.72	9.6	21.9	26.86
Net Cash (Debt)	2,976	2,991	3,106	3,675	4,072	4,676
Net Cash Growth	-9.45%	-3.69%	-15.48%	-9.75%	-12.92%	-8.88%
Net Cash Per Share	45.15	45.39	47.10	55.74	61.98	71.39
Filing Date Shares Outstanding	65.87	65.9	65.9	65.9	65.84	65.65
Total Common Shares Outstanding	65.87	65.9	65.9	65.9	65.84	65.55
Working Capital	2,960	2,927	3,004	3,433	3,714	4,295
Book Value Per Share	49.39	49.10	43.96	42.42	38.37	40.32
Tangible Book Value	3,253	3,235	2,669	2,607	2,320	2,595
Tangible Book Value Per Share	49.38	49.09	40.51	39.56	35.24	39.59
Land	-	84.99	86.01	90.71	88.72	26.13
Machinery	-	37.92	56.75	49.03	67.28	54.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.